Overview

A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1

Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
0
Participant gender:
All
Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the gastrointestinal mucosain vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is an exploratory study of a confocal endoscope designed to evaluate the feasibility of using this FDA-approved device in the endoscopic surveillance of subjects at high-risk for neoplasia in the upper and lower GI tract. The confocal endoscope provides real-time in vivo microscopic images of the mucosa which resemble standard pathology.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Anandasabapathy, Sharmila, M.D.
Treatments:
Proflavine
Criteria
Inclusion Criteria:

- patient 18 years or older

- colonoscopy for screening or surveillance of polyps or disease of colon

- anoscopy because of suspected or known anal dysplasia or neoplasia

Exclusion Criteria:

- patient unable to provide informed consent

- patient found unfit for standard colonoscopy or anoscopy with biopsies